retatrutide clinical trial results 2025 Timeline: Week-by-Week (48 Weeks) retatrutide 2025 trial results Retatrutide

A Master Protocol to Investigate Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight, including Knee Osteoarthritis substudy (TRIUMPH-1, NCT05929066)

However, anyone considering a GLP-1 patch should discuss it with a healthcare professional to understand whether its safe for their specific health needs

Medical weight loss injections are most effective when combined with lifestyle changes, including balanced nutrition and regular physical activity

More recent studies of isolated acini from mouse and rat pancreas showed a small but dose dependent stimulation of amylase release comparable to that induced by VIP or secretin (54, 98)